TrialCancer biology & therapy2022

Evaluation of the efficacy of the anti-ulcer oral mucosal protective agent RADoralex® in the prevention and treatment of radiation-induced oral mucosal reactions induced during treatment of nasopharyngeal carcinoma.

Jun Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.